Clinical Trial Update: Clinical Trial of PCV24 in Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of PCV24 in adults has completed, with the sponsor reporting the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• PCV24 (24-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Sinovac Life Sciences Co., Ltd. | Conditions: Pneumococcal Infectious Disease | Phase 1 | Status: COMPLETED